erythromycin has been researched along with tinidazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blenk, H; Hofstetter, A | 1 |
| Dahlbäck, A; Dornbusch, K; Nord, CE | 1 |
| Dornbusch, K; Holmberg, K; Nord, CE | 1 |
| Friberg, D; Lundberg, C | 1 |
| Knight, R | 1 |
| Aho, P; Höök-Nikanne, J; Kärkkäinen, P; Kosunen, TU; Salaspuro, M | 1 |
1 review(s) available for erythromycin and tinidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for erythromycin and tinidazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Therapy of prostato-vesiculitis].
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Chlamydia; Erythromycin; Genital Diseases, Male; Humans; Male; Mycoplasma; Prostatitis; Seminal Vesicles; Tetracycline; Tinidazole; Trichomonas Infections | 1978 |
Antibiotic susceptibility of Clostridium species isolated from human infections.
Topics: Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Clindamycin; Clostridium; Clostridium perfringens; Doxycycline; Erythromycin; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Tetracycline; Tinidazole | 1975 |
Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica.
Topics: Actinomyces; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Sulfanilamides; Tetracycline; Tinidazole | 1977 |
Antibiotic prophylaxis in major head and neck surgery when clean-contaminated wounds are established.
Topics: Erythromycin; Head and Neck Neoplasms; Humans; Penicillin G; Premedication; Retrospective Studies; Surgical Wound Infection; Tinidazole | 1990 |
The chemotherapy of amoebiasis.
Topics: Acetanilides; Amebiasis; Amebicides; Arsenicals; Carrier State; Chloroquine; Dysentery, Amebic; Emetine; Entamoebiasis; Erythromycin; Furans; Humans; Hydroxyquinolines; Metronidazole; Nitroimidazoles; Paromomycin; Tetracyclines; Tinidazole | 1980 |
The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Catechols; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gastric Mucosa; Helicobacter Infections; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentanones; Tetracycline; Tinidazole | 1996 |